Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Spain Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20051
20063
20075
20081
20092
20101
20111
20146
20154
20162
20171
20183
20197
20203
20211
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated7
Active, not recruiting2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie7
Adamas Pharmaceuticals, Inc.4
Impax Laboratories, LLC4
Acorda Therapeutics3
GlaxoSmithKline3
Theravance Biopharma3
UCB Pharma3
Boehringer Ingelheim2
Intec Pharma Ltd.2
Newron Pharmaceuticals SPA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease49
Parkinsonian Disorders10
Dyskinesias8
Brain Diseases4
Central Nervous System Diseases4
Movement Disorders4
Nervous System Diseases4
Neurodegenerative Diseases4
Dizziness3
Hypotension3

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.